IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

Arthritis Research

Volumn 3, Issue 3, 2001, Pages 168-177

  Chabaud, Martine ^a   Lubberts, Erik ^b   Joosten, Leo ^b   Van Den Berg, Wim ^b   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone; Cartilage; Degradation; IL 17; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 7; MONOCLONAL ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEOGLYCAN; SOMATOMEDIN C; SULFATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE MARROW CELL; CARTILAGE DEGENERATION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRADATION; DRUG MECHANISM; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PROTEOGLYCAN SYNTHESIS; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; TISSUE CULTURE; TREATMENT PLANNING;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; BONE AND BONES; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN; DRUG COMBINATIONS; INJECTIONS, INTRA-ARTICULAR; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1; INTERLEUKIN-17; INTERLEUKIN-6; KNEE JOINT; MICE; MICE, INBRED C57BL; PROTEOGLYCANS; SYNOVIAL MEMBRANE;

EID: 0035048597     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar294     Document Type: Article

References (43)

1. The pathophysiology and treatment of rheumatoid arthritis
2. Human Th1 cells preferentially induce interleukin (IL)-1 beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes
3. Contribution of IL-1, CD 14, CD 13 in the increased IL-6 production during monocyte synoviocyte interactions
4. Role of cytokines in bone resorption
5. Prostaglandin E2, interleukin-1a, and tumor necrosis factor-α, increase human osteoblast formation and bone resorption in vitro
6. Activated T lymphocytes support osteoclast formation in vitro
7. Effects of murine recombinant interleukin-1 on synovial joints in mice; measurement of patella cartilage metabolism and joint inflammation
8. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis
9. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
10. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
11. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal anti-body combined with low-dose weekly methotrexate in rheumatoid arthritis
12. Treatment of rheumatoid arthritis with recombinant interleukin-1 receptor antagonist
13. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
14. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor
15. Interleukin-7 stimulates osteoclast formation by upregulating the T-cell production of soluble osteoclastogenic cytokines
16. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
17. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
18. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells
19. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
20. Interleukin-17: A new bone acting cytokine in vitro
21. IL-17 enhances the effects of IL-1 on IL-6 and LIF production by rheumatoid arthritis synoviocytes
22. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
23. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
24. Interleukin 4 inhibits ex vivo production of proinflammatory cytokines and immunoglobulins by rheumatoid synovitis
25. Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis
26. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen
27. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
28. Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples
29. Regulatory role of interleukin-10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. Murine therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone
30. Insulin-like growth factor stimulation of articular chondrocyte proteoglycan synthesis. Availability and responses at different ages
31. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells
32. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages
33. Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium
34. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells
35. Contribution of interleukin-17 to synovium matrix destruction in rheumatoid arthritis
36. Interleukin-17 upregulation of nitric oxide production in human osteoarthritis cartilage
37. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB
38. Effect of interleukin 17 on proteoglycan degradation in murine knee joints
39. A role for CD8+ T lymphocytes in osteoclast differentiation in vitro
40. Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development
41. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
42. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis
43. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion